1. Home
  2. HYI vs SEER Comparison

HYI vs SEER Comparison

Compare HYI & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset High Yield Defined Opportunity Fund Inc.

HYI

Western Asset High Yield Defined Opportunity Fund Inc.

SELL

Current Price

$9.24

Market Cap

135.2M

Sector

Finance

ML Signal

SELL

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.35

Market Cap

113.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYI
SEER
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
135.2M
113.0M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
HYI
SEER
Price
$9.24
$1.35
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
96.8K
★ 157.6K
Earning Date
01-01-0001
11-10-2026
Dividend Yield
★ 9.59%
N/A
EPS Growth
N/A
★ 9.40
EPS
★ N/A
N/A
Revenue
N/A
★ $16,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.50
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.99
52 Week Low
$9.42
$1.36
52 Week High
$11.26
$2.38

Technical Indicators

Market Signals
Indicator
HYI
SEER
Relative Strength Index (RSI) 28.03 19.60
Support Level N/A N/A
Resistance Level $10.66 $1.81
Average True Range (ATR) 0.14 0.11
MACD -0.03 -0.02
Stochastic Oscillator 5.69 4.44

Price Performance

Historical Comparison
HYI
SEER

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: